YDES vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 02, 2026

YDES

46.1
AI Score
VS
YDES Wins

CBIO

45.7
AI Score

Investment Advisor Scores

YDES

46score
Recommendation
HOLD

CBIO

46score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric YDES CBIO Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 95.6% 0.0% YDES
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 46.1/100 45.7/100 YDES
Profit Margin -276.6% 0.0% CBIO
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

YDES 1M: -0.9% · 3M: -53.8% CBIO 1M: -3.4% · 3M: -8.6%

Current Technical Phase

YDES

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.4 · Price: $2.32

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.2 · Price: $16.38

Fundamentals Snapshot

Metric YDES CBIO
Market Cap
Forward P/E 0.0 -6.2
Trailing P/E
Revenue (TTM)
Revenue Growth 1.0% 0.0%
Gross Margin 0.3% 1.0%
Operating Margin -4.4% -14.3%
EPS -0.12 -0.14
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, YDES is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.